The protocol at a glance
There is no human dose for the blend. If the vial is made as 50 mg GHK-Cu plus 10 mg each of KPV, BPC-157 and TB-500, every 1 mg of powder holds 625 mcg GHK-Cu and 125 mcg of each of the others.
| Item | What is known |
|---|---|
| Human dose of the blend | Not established |
| Studied in | Never tested as a blend in people |
| Per 1 mg of powder (80 mg vial) | 625 mcg GHK-Cu, 125 mcg each of KPV, BPC-157 and TB-500 |
The per-milligram split is our arithmetic from the stated 50 + 10 + 10 + 10 mg mix. It is not a trial or label amount.
Community reports commonly describe 1 to 4 mg of the blend a day. These are user reports, not trial doses.
What people say they do, collected from community discussions. Not tested in a trial; shown so you can compare it with the evidence above.
Mixing
No mixing table here: this one is used as a capsule, nasal spray or skin product, or has no human amount to calculate from. The general mixing calculator works for any vial.
What the trials found
No human results exist for the blend or for most of its parts:
See the KPV, BPC-157, TB-500 and GHK-Cu pages for what each part has been tested for.
Side effects
- There is no human safety data for the blend.
- Four products in one vial add unknowns. KPV has no human safety data at all.
How it works
GHK-Cu part (lab data)
Lab studies point to collagen rebuilding and wound repair; human use so far is on the skin.
KPV part (mouse and cell data)
Reduced gut inflammation in mice; works through the PepT1 transporter in cells.
BPC-157 and TB-500 parts (animal and lab data)
Linked to cell survival, cell movement and repair in tendon and cell studies.
Sources
- Same sources as the KPV, BPC-157, TB-500 and GHK-Cu pages
- Composition arithmetic: 50 / 80 mg = 625 mcg per mg; 10 / 80 mg = 125 mcg per mg